De effecten
Elk effect in het gevolgde universum, gerangschikt op wie het bezit — aantal houders, gerapporteerde waarde en de richting van verandering.
Eigendomscijfers tellen uitsluitend gevolgde 13F-managers mee en hebben betrekking op de rapportageperiode Q2 2026 · koersen, waar getoond, zijn vertraagd en staan los van de aangiftegegevens
| # | Effect | Sector | Houders | Δ | Nieuw | Uitstappen | Gerapporteerde waarde | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 | LLY Eli Lilly and Company | Healthcare | 193 | +4 | +6 | −1 | $804.91B | Stable |
| 2 | JNJ Johnson & Johnson | Healthcare | 183 | +1 | +5 | −3 | $367.13B | Stable |
| 3 | ABBV AbbVie Inc. | Healthcare | 183 | +6 | +9 | −2 | $270.09B | Rising |
| 4 | UNH UnitedHealth Group… | Healthcare | 192 | +4 | +9 | −4 | $264.40B | Rising |
| 5 | MRK Merck & Co., Inc. | Healthcare | 183 | 0 | +4 | −3 | $205.60B | Stable |
| 6 | AMGN Amgen Inc. | Healthcare | 171 | -1 | +5 | −5 | $133.70B | Stable |
| 7 | TMO Thermo Fisher Scientific… | Healthcare | 191 | +3 | +5 | −1 | $131.45B | Stable |
| 8 | GILD Gilead Sciences, Inc. | Healthcare | 175 | +1 | +5 | −3 | $119.07B | Stable |
| 9 | AZN AstraZeneca PLC | Healthcare | 156 | +6 | +11 | −4 | $113.17B | Rising |
| 10 | VRTX Vertex Pharmaceuticals… | Healthcare | 175 | -1 | +5 | −5 | $105.17B | Stable |
| 11 | ABT Abbott Laboratories | Healthcare | 182 | 0 | +5 | −4 | $99.82B | Stable |
| 12 | ISRG Intuitive Surgical, Inc. | Healthcare | 181 | -1 | +4 | −4 | $99.08B | Stable |
| 13 | CVS CVS Health Corp. | Healthcare | 183 | +1 | +4 | −2 | $98.99B | Stable |
| 14 | DHR Danaher Corporation | Healthcare | 190 | +7 | +10 | −2 | $83.49B | Stable |
| 15 | BMY Bristol-Myers Squibb… | Healthcare | 174 | +1 | +6 | −4 | $76.47B | Stable |
| 16 | PFE Pfizer Inc. | Healthcare | 175 | +3 | +7 | −3 | $73.90B | Stable |
| 17 | SYK Stryker Corporation | Healthcare | 172 | +2 | +7 | −4 | $70.41B | Stable |
| 18 | MDT Medtronic plc | Healthcare | 175 | +1 | +6 | −4 | $69.47B | Stable |
| 19 | MCK McKesson Corporation | Healthcare | 172 | 0 | +6 | −5 | $64.24B | Stable |
| 20 | ELV Elevance Health Inc. | Healthcare | 179 | +1 | +7 | −5 | $61.93B | Stable |
| 21 | CI Cigna Corporation | Healthcare | 179 | 0 | +4 | −3 | $55.09B | Stable |
| 22 | REGN Regeneron… | Healthcare | 169 | -1 | +5 | −5 | $47.53B | Stable |
| 23 | BSX Boston Scientific… | Healthcare | 182 | -1 | +3 | −3 | $46.05B | Stable |
| 24 | COR Cencora, Inc. | Healthcare | 163 | 0 | +5 | −4 | $39.83B | Stable |
| 25 | HCA HCA Healthcare, Inc. | Healthcare | 164 | -3 | +4 | −6 | $39.46B | Falling |
| 26 | CAH Cardinal Health, Inc. | Healthcare | 172 | +5 | +9 | −3 | $38.69B | Rising |
| 27 | EW Edwards Lifesciences… | Healthcare | 165 | -6 | +2 | −7 | $38.52B | Stable |
| 28 | HUM Humana Inc. | Healthcare | 167 | +7 | +13 | −5 | $34.28B | Rising |
| 29 | ALNY Alnylam Pharmaceuticals… | Healthcare | 162 | +3 | +7 | −3 | $32.37B | Stable |
| 30 | BDX Becton, Dickinson and… | Healthcare | 160 | -1 | +7 | −7 | $30.73B | Stable |
| 31 | IDXX IDEXX Laboratories, Inc. | Healthcare | 168 | 0 | +7 | −6 | $29.30B | Stable |
| 32 | NTRA Natera, Inc. | Healthcare | 162 | 0 | +5 | −4 | $28.25B | Stable |
| 33 | WAT Waters Corporation | Healthcare | 163 | +2 | +7 | −4 | $27.38B | Rising |
| 34 | A Agilent Technologies, Inc. | Healthcare | 166 | +3 | +9 | −5 | $26.02B | Rising |
| 35 | BIIB Biogen Inc. | Healthcare | 161 | 0 | +6 | −5 | $25.77B | Rising |
| 36 | CNC Centene Corp. | Healthcare | 169 | +2 | +5 | −2 | $24.37B | Rising |
| 37 | IQV IQVIA Holdings Inc. | Healthcare | 166 | +9 | +12 | −2 | $23.68B | Rising |
| 38 | ILMN Illumina, Inc. | Healthcare | 164 | +8 | +11 | −2 | $20.61B | Rising |
| 39 | DXCM DexCom, Inc. | Healthcare | 168 | +1 | +7 | −5 | $20.50B | Stable |
| 40 | ZTS Zoetis Inc. | Healthcare | 175 | +5 | +9 | −3 | $20.34B | Stable |
| 41 | GEHC GE HealthCare… | Healthcare | 167 | -4 | +7 | −10 | $19.48B | Falling |
| 42 | MTD Mettler-Toledo… | Healthcare | 162 | +3 | +6 | −2 | $19.38B | Rising |
| 43 | ARGX argenx SE | Healthcare | 121 | +5 | +10 | −5 | $19.06B | Stable |
| 44 | RVMD Revolution Medicines, Inc. | Healthcare | 149 | +17 | +25 | −7 | $18.63B | Strongly Rising |
| 45 | MRNA Moderna, Inc. | Healthcare | 147 | +2 | +8 | −5 | $18.50B | Rising |
| 46 | WST West Pharmaceutical… | Healthcare | 162 | +3 | +8 | −4 | $18.07B | Stable |
| 47 | RPRX Royalty Pharma plc | Healthcare | 146 | 0 | +5 | −4 | $17.19B | Stable |
| 48 | DGX Quest Diagnostics… | Healthcare | 155 | +1 | +7 | −5 | $16.53B | Stable |
| 49 | NVS Novartis AG | Healthcare | 125 | +1 | +8 | −7 | $16.04B | Falling |
| 50 | LH Labcorp Holdings Inc. | Healthcare | 158 | +5 | +9 | −3 | $15.83B | Rising |
| 51 | INSM Insmed Incorporated | Healthcare | 158 | -6 | +6 | −11 | $15.74B | Falling |
| 52 | UTHR United Therapeutics… | Healthcare | 159 | +4 | +8 | −3 | $15.29B | Stable |
| 53 | GSK GSK plc | Healthcare | 118 | +2 | +8 | −5 | $15.17B | Stable |
| 54 | INCY Incyte Corporation | Healthcare | 156 | 0 | +4 | −3 | $15.06B | Stable |
| 55 | RMD ResMed Inc. | Healthcare | 159 | +2 | +7 | −4 | $14.96B | Rising |
| 56 | MDLN Medline Inc. | Healthcare | 137 | +28 | +39 | −10 | $14.75B | Strongly Rising |
| 57 | ROIV Roivant Sciences Ltd. | Healthcare | 131 | +11 | +15 | −3 | $14.45B | Rising |
| 58 | STE STERIS plc | Healthcare | 155 | 0 | +9 | −8 | $14.06B | Stable |
| 59 | GH Guardant Health, Inc. | Healthcare | 139 | +11 | +17 | −5 | $13.96B | Rising |
| 60 | ZBH Zimmer Biomet Holdings… | Healthcare | 158 | +1 | +8 | −6 | $13.80B | Stable |
| 61 | NBIX Neurocrine Biosciences… | Healthcare | 154 | 0 | +5 | −4 | $12.81B | Stable |
| 62 | TEVA Teva Pharmaceutical… | Healthcare | 151 | +7 | +9 | −1 | $12.48B | Rising |
| 63 | THC Tenet Healthcare… | Healthcare | 139 | +1 | +9 | −7 | $12.09B | Stable |
| 64 | VTRS Viatris Inc. | Healthcare | 150 | -1 | +6 | −6 | $12.03B | Rising |
| 65 | DVA DaVita Inc. | Healthcare | 151 | +2 | +7 | −4 | $11.55B | Stable |
| 66 | JAZZ Jazz Pharmaceuticals plc | Healthcare | 137 | +4 | +7 | −2 | $11.43B | Stable |
| 67 | NVO Novo Nordisk A/S | Healthcare | 134 | +1 | +13 | −12 | $11.33B | Stable |
| 68 | IONS Ionis Pharmaceuticals… | Healthcare | 139 | +2 | +6 | −3 | $11.08B | Rising |
| 69 | ALC Alcon Inc. | Healthcare | 127 | 0 | +8 | −7 | $10.99B | Stable |
| 70 | ELAN Elanco Animal Health… | Healthcare | 130 | +5 | +12 | −6 | $10.50B | Rising |
| 71 | CRL Charles River… | Healthcare | 140 | -1 | +6 | −6 | $10.31B | Stable |
| 72 | EXEL Exelixis, Inc. | Healthcare | 140 | -1 | +5 | −5 | $9.80B | Stable |
| 73 | COO The Cooper Companies, Inc. | Healthcare | 151 | +2 | +8 | −5 | $9.69B | Rising |
| 74 | ALGN Align Technology, Inc. | Healthcare | 154 | -2 | +4 | −5 | $9.61B | Stable |
| 75 | BTSG BrightSpring Health… | Healthcare | 119 | +18 | +23 | −4 | $9.55B | Strongly Rising |
| 76 | MOH Molina Healthcare, Inc. | Healthcare | 134 | +9 | +17 | −7 | $9.52B | Rising |
| 77 | ICLR ICON Public Limited… | Healthcare | 113 | +2 | +10 | −7 | $9.34B | Rising |
| 78 | MEDP Medpace Holdings, Inc. | Healthcare | 131 | -10 | +3 | −12 | $8.90B | Stable |
| 79 | BBIO BridgeBio Pharma, Inc. | Healthcare | 134 | +3 | +10 | −6 | $8.70B | Rising |
| 80 | BMRN BioMarin Pharmaceutical… | Healthcare | 137 | +4 | +11 | −6 | $8.41B | Stable |
| 81 | TECH Bio-Techne Corporation | Healthcare | 147 | +11 | +19 | −7 | $8.37B | Rising |
| 82 | BAX Baxter International Inc. | Healthcare | 138 | -1 | +8 | −8 | $8.34B | Stable |
| 83 | PODD Insulet Corp. | Healthcare | 160 | 0 | +7 | −6 | $8.15B | Stable |
| 84 | CYTK Cytokinetics, Incorporated | Healthcare | 128 | +7 | +10 | −2 | $8.15B | Rising |
| 85 | ASND Ascendis Pharma A/S | Healthcare | 106 | +15 | +25 | −10 | $7.62B | Strongly Rising |
| 86 | RVTY Revvity, Inc. | Healthcare | 133 | +9 | +14 | −4 | $7.35B | Rising |
| 87 | PEN Penumbra, Inc. | Healthcare | 116 | -12 | +3 | −14 | $7.07B | Falling |
| 88 | KRYS Krystal Biotech, Inc. | Healthcare | 109 | +2 | +12 | −9 | $7.04B | Rising |
| 89 | EHC Encompass Health… | Healthcare | 133 | -3 | +2 | −4 | $7.02B | Stable |
| 90 | AXSM Axsome Therapeutics, Inc. | Healthcare | 131 | +8 | +16 | −7 | $6.75B | Rising |
| 91 | HALO Halozyme Therapeutics… | Healthcare | 132 | -2 | +5 | −6 | $6.60B | Stable |
| 92 | HSIC Henry Schein, Inc. | Healthcare | 142 | +5 | +10 | −4 | $6.47B | Rising |
| 93 | ALKS Alkermes plc | Healthcare | 121 | +1 | +12 | −10 | $6.45B | Stable |
| 94 | ONC BeOne Medicines AG | Healthcare | 94 | -5 | +5 | −10 | $6.43B | Stable |
| 95 | ARWR Arrowhead… | Healthcare | 133 | +6 | +14 | −7 | $6.29B | Stable |
| 96 | SNY Sanofi | Healthcare | 111 | +6 | +8 | −2 | $6.22B | Stable |
| 97 | SOLV Solventum Corporation | Healthcare | 151 | +2 | +13 | −10 | $6.20B | Stable |
| 98 | KYMR Kymera Therapeutics, Inc. | Healthcare | 101 | +12 | +14 | −1 | $6.01B | Strongly Rising |
| 99 | GKOS Glaukos Corporation | Healthcare | 125 | +9 | +15 | −5 | $5.95B | Rising |
| 100 | UHS Universal Health… | Healthcare | 146 | -7 | +5 | −11 | $5.83B | Falling |
| 101 | ENSG The Ensign Group, Inc. | Healthcare | 130 | -2 | +9 | −10 | $5.82B | Falling |
| 102 | GMED Globus Medical, Inc. | Healthcare | 123 | -3 | +7 | −9 | $5.66B | Rising |
| 103 | TWST Twist Bioscience… | Healthcare | 113 | +8 | +14 | −6 | $5.62B | Rising |
| 104 | MDGL Madrigal Pharmaceuticals… | Healthcare | 123 | +1 | +9 | −7 | $5.62B | Stable |
| 105 | LNTH Lantheus Holdings, Inc. | Healthcare | 130 | +6 | +14 | −7 | $5.58B | Stable |
| 106 | PTGX Protagonist Therapeutics… | Healthcare | 106 | +1 | +7 | −6 | $5.57B | Stable |
| 107 | PRAX Praxis Precision… | Healthcare | 111 | +10 | +16 | −5 | $5.55B | Strongly Rising |
| 108 | RGEN Repligen Corporation | Healthcare | 126 | +8 | +16 | −7 | $5.47B | Rising |
| 109 | ATR AptarGroup, Inc. | Healthcare | 122 | -2 | +4 | −5 | $5.34B | Stable |
| 110 | HQY HealthEquity, Inc. | Healthcare | 121 | -1 | +6 | −6 | $5.13B | Stable |
| 111 | PCVX Vaxcyte, Inc. | Healthcare | 114 | +1 | +6 | −4 | $4.99B | Rising |
| 112 | SYRE Spyre Therapeutics, Inc. | Healthcare | 99 | +22 | +25 | −3 | $4.93B | Strongly Rising |
| 113 | HLN Haleon plc | Healthcare | 105 | +5 | +8 | −2 | $4.91B | Rising |
| 114 | RYTM Rhythm Pharmaceuticals… | Healthcare | 113 | +6 | +14 | −7 | $4.90B | Rising |
| 115 | BRKR Bruker Corporation | Healthcare | 119 | +10 | +18 | −7 | $4.87B | Rising |
| 116 | SRRK Scholar Rock Holding… | Healthcare | 105 | +5 | +10 | −4 | $4.79B | Strongly Rising |
| 117 | PTCT PTC Therapeutics, Inc. | Healthcare | 115 | +8 | +13 | −5 | $4.78B | Rising |
| 118 | LGND Ligand Pharmaceuticals… | Healthcare | 110 | +7 | +13 | −6 | $4.69B | Rising |
| 119 | TGTX TG Therapeutics, Inc. | Healthcare | 117 | +11 | +13 | −2 | $4.64B | Strongly Rising |
| 120 | CORT Corcept Therapeutics… | Healthcare | 115 | +10 | +17 | −6 | $4.56B | Rising |
| 121 | TEM Tempus AI, Inc. | Healthcare | 107 | -4 | +6 | −9 | $4.53B | Rising |
| 122 | AVTR Avantor, Inc. | Healthcare | 114 | -6 | +7 | −12 | $4.42B | Stable |
| 123 | COGT Cogent Biosciences, Inc. | Healthcare | 104 | +4 | +7 | −3 | $4.20B | Rising |
| 124 | BIO Bio-Rad Laboratories, Inc. | Healthcare | 117 | -3 | +7 | −9 | $4.19B | Stable |
| 125 | APGE Apogee Therapeutics, Inc. | Healthcare | 105 | +12 | +21 | −9 | $4.18B | Stable |
| 126 | MIRM Mirum Pharmaceuticals… | Healthcare | 106 | +2 | +9 | −7 | $4.18B | Rising |
| 127 | CHE Chemed Corporation | Healthcare | 133 | +6 | +9 | −2 | $4.16B | Rising |
| 128 | VCYT Veracyte, Inc. | Healthcare | 119 | +4 | +10 | −6 | $3.96B | Rising |
| 129 | HIMS Hims & Hers Health, Inc. | Healthcare | 118 | +5 | +12 | −7 | $3.93B | Rising |
| 130 | OSCR Oscar Health, Inc. | Healthcare | 123 | +14 | +21 | −6 | $3.91B | Strongly Rising |
| 131 | TXG 10x Genomics, Inc. | Healthcare | 114 | +7 | +16 | −8 | $3.78B | Rising |
| 132 | ORKA Oruka Therapeutics, Inc. | Healthcare | 98 | +25 | +30 | −5 | $3.69B | Strongly Rising |
| 133 | ALHC Alignment Healthcare, Inc. | Healthcare | 105 | -3 | +9 | −12 | $3.65B | Rising |
| 134 | TVTX Travere Therapeutics, Inc. | Healthcare | 113 | +16 | +20 | −4 | $3.63B | Strongly Rising |
| 135 | LIVN LivaNova PLC | Healthcare | 100 | -4 | +8 | −11 | $3.63B | Falling |
| 136 | DNTH Dianthus Therapeutics… | Healthcare | 96 | +12 | +16 | −4 | $3.56B | Strongly Rising |
| 137 | NUVL Nuvalent, Inc. | Healthcare | 97 | +1 | +17 | −15 | $3.50B | Strongly Falling |
| 138 | NVST Envista Holdings Corp | Healthcare | 108 | -2 | +8 | −9 | $3.47B | Stable |
| 139 | XENE Xenon Pharmaceuticals Inc. | Healthcare | 114 | +7 | +11 | −4 | $3.35B | Rising |
| 140 | TFX Teleflex Incorporated | Healthcare | 114 | +2 | +8 | −5 | $3.34B | Rising |
| 141 | INDV Indivior Pharmaceuticals… | Healthcare | 107 | +12 | +17 | −5 | $3.27B | Rising |
| 142 | CGON CG Oncology Inc. | Healthcare | 94 | +7 | +12 | −5 | $3.24B | Rising |
| 143 | RDNT RadNet, Inc. | Healthcare | 104 | -5 | +4 | −8 | $3.16B | Stable |
| 144 | DFTX Definium Therapeutics… | Healthcare | 105 | +21 | +25 | −4 | $3.02B | Strongly Rising |
| 145 | BNTX BioNTech SE | Healthcare | 94 | 0 | +8 | −8 | $3.02B | Rising |
| 146 | LQDA Liquidia Corporation | Healthcare | 100 | +24 | +27 | −3 | $2.92B | Strongly Rising |
| 147 | MMSI Merit Medical Systems… | Healthcare | 119 | +2 | +12 | −9 | $2.86B | Rising |
| 148 | TNGX Tango Therapeutics, Inc. | Healthcare | 96 | +22 | +24 | −2 | $2.83B | Strongly Rising |
| 149 | CRSP CRISPR Therapeutics AG | Healthcare | 115 | +5 | +10 | −4 | $2.83B | Rising |
| 150 | IRTC iRhythm Technologies, Inc. | Healthcare | 105 | -5 | +4 | −8 | $2.82B | Falling |
| 151 | HNGE Hinge Health, Inc. | Healthcare | 104 | +27 | +31 | −3 | $2.70B | Strongly Rising |
| 152 | ITGR Integer Holdings… | Healthcare | 103 | +2 | +9 | −7 | $2.69B | Rising |
| 153 | CRNX Crinetics… | Healthcare | 89 | -1 | +5 | −6 | $2.68B | Stable |
| 154 | DNLI Denali Therapeutics Inc. | Healthcare | 97 | +6 | +11 | −4 | $2.65B | Rising |
| 155 | HAE Haemonetics Corporation | Healthcare | 106 | -6 | +3 | −9 | $2.63B | Falling |
| 156 | BKD Brookdale Senior Living… | Healthcare | 101 | -1 | +4 | −5 | $2.55B | Stable |
| 157 | CELC Celcuity Inc. | Healthcare | 99 | +6 | +12 | −6 | $2.54B | Strongly Rising |
| 158 | ACHC Acadia Healthcare… | Healthcare | 97 | +7 | +14 | −7 | $2.54B | Rising |
| 159 | CON Concentra Group Holdings… | Healthcare | 96 | +5 | +11 | −5 | $2.53B | Rising |
| 160 | IDYA IDEAYA Biosciences, Inc. | Healthcare | 100 | +4 | +10 | −5 | $2.53B | Rising |
| 161 | ADPT Adaptive Biotechnologies… | Healthcare | 107 | 0 | +6 | −6 | $2.46B | Stable |
| 162 | BEAM Beam Therapeutics Inc. | Healthcare | 98 | +9 | +12 | −3 | $2.45B | Rising |
| 163 | ICUI ICU Medical, Inc. | Healthcare | 102 | 0 | +7 | −6 | $2.44B | Stable |
| 164 | CPRX Catalyst Pharmaceuticals… | Healthcare | 109 | -4 | +12 | −16 | $2.42B | Stable |
| 165 | OPCH Option Care Health, Inc. | Healthcare | 117 | -1 | +10 | −10 | $2.42B | Stable |
| 166 | WAY Waystar Holding Corp. | Healthcare | 101 | -4 | +11 | −14 | $2.39B | Stable |
| 167 | MANE Veradermics, Incorporated | Healthcare | 66 | +28 | +31 | −3 | $2.30B | Strongly Rising |
| 168 | ACAD ACADIA Pharmaceuticals… | Healthcare | 122 | +9 | +11 | −1 | $2.30B | Rising |
| 169 | VKTX Viking Therapeutics, Inc. | Healthcare | 109 | +6 | +10 | −4 | $2.25B | Rising |
| 170 | IMVT Immunovant, Inc. | Healthcare | 92 | +8 | +14 | −5 | $2.24B | Strongly Rising |
| 171 | LFST LifeStance Health Group… | Healthcare | 95 | +6 | +9 | −3 | $2.19B | Strongly Rising |
| 172 | DOCS Doximity, Inc. | Healthcare | 114 | -8 | +7 | −14 | $2.11B | Stable |
| 173 | ABVX Abivax S.A. | Healthcare | 83 | +12 | +16 | −3 | $2.06B | Rising |
| 174 | PRVA Privia Health Group, Inc. | Healthcare | 102 | +2 | +6 | −4 | $2.05B | Rising |
| 175 | RLAY Relay Therapeutics, Inc. | Healthcare | 94 | +5 | +12 | −7 | $2.04B | Strongly Rising |
| 176 | SHC Sotera Health Company | Healthcare | 93 | -4 | +6 | −9 | $2.03B | Rising |
| 177 | ERAS Erasca, Inc. | Healthcare | 97 | +13 | +17 | −4 | $2.01B | Strongly Rising |
| 178 | RARE Ultragenyx Pharmaceutical… | Healthcare | 97 | -7 | +8 | −14 | $1.99B | Stable |
| 179 | SUPN Supernus Pharmaceuticals… | Healthcare | 103 | +2 | +5 | −3 | $1.97B | Rising |
| 180 | RCUS Arcus Biosciences, Inc. | Healthcare | 83 | +1 | +8 | −7 | $1.91B | Rising |
| 181 | CLDX Celldex Therapeutics, Inc. | Healthcare | 87 | +8 | +11 | −3 | $1.89B | Strongly Rising |
| 182 | ELVN Enliven Therapeutics, Inc. | Healthcare | 80 | +12 | +15 | −3 | $1.84B | Strongly Rising |
| 183 | AMRX Amneal Pharmaceuticals… | Healthcare | 101 | -4 | +7 | −10 | $1.84B | Stable |
| 184 | ARQT Arcutis Biotherapeutics… | Healthcare | 105 | +8 | +11 | −2 | $1.82B | Rising |
| 185 | LEGN Legend Biotech Corporation | Healthcare | 91 | +11 | +16 | −5 | $1.78B | Strongly Rising |
| 186 | NTLA Intellia Therapeutics… | Healthcare | 108 | +3 | +8 | −5 | $1.74B | Strongly Rising |
| 187 | TMDX TransMedics Group, Inc. | Healthcare | 105 | -3 | +11 | −13 | $1.72B | Falling |
| 188 | OGN Organon & Co. | Healthcare | 112 | -5 | +9 | −13 | $1.69B | Falling |
| 189 | IRON Disc Medicine, Inc. | Healthcare | 83 | +7 | +9 | −2 | $1.68B | Rising |
| 190 | VERA Vera Therapeutics, Inc. | Healthcare | 83 | -2 | +6 | −8 | $1.68B | Rising |
| 191 | CAI Caris Life Sciences, Inc. | Healthcare | 91 | +10 | +15 | −5 | $1.67B | Strongly Rising |
| 192 | TARS Tarsus Pharmaceuticals… | Healthcare | 102 | +3 | +7 | −3 | $1.67B | Rising |
| 193 | DYN Dyne Therapeutics, Inc. | Healthcare | 86 | +1 | +7 | −5 | $1.63B | Rising |
| 194 | EWTX Edgewise Therapeutics… | Healthcare | 87 | +8 | +13 | −4 | $1.62B | Strongly Rising |
| 195 | PBH Prestige Consumer… | Healthcare | 102 | -6 | +5 | −10 | $1.61B | Falling |
| 196 | PGNY Progyny, Inc. | Healthcare | 111 | +7 | +10 | −2 | $1.59B | Rising |
| 197 | GPCR Structure Therapeutics… | Healthcare | 66 | 0 | +7 | −7 | $1.56B | Stable |
| 198 | RDY Dr. Reddy's Laboratories… | Healthcare | 83 | +2 | +6 | −4 | $1.53B | Rising |
| 199 | OMCL Omnicell, Inc. | Healthcare | 99 | +2 | +8 | −6 | $1.52B | Stable |
| 200 | NHC National HealthCare… | Healthcare | 84 | +5 | +9 | −4 | $1.51B | Rising |
Δ = verandering in het aantal gevolgde houders ten opzichte van het vergelijkbare voorgaande kwartaal. Gebruik voor uitgebreidere filters de screener.
Herkomst: Geaggregeerd uit geparseerde 13F-posities in gewone aandelen van het gevolgde universum; vergelijkbare managerssets voor alle wijzigingen.
Methodologie